|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-9-2
|
|
pubmed:abstractText |
There is critical need for standardization of HER2 immunohistochemistry testing in the clinical laboratory setting. Recently, the American Society of Clinical Oncology and the College of American Pathologists have submitted guidelines recommending that laboratories achieve 95% concordance between assays and observers for HER2 testing.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1543-2165
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
133
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1413-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:19722747-Algorithms,
pubmed-meshheading:19722747-Breast Neoplasms,
pubmed-meshheading:19722747-Carcinoma, Ductal, Breast,
pubmed-meshheading:19722747-Female,
pubmed-meshheading:19722747-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:19722747-Guidelines as Topic,
pubmed-meshheading:19722747-Humans,
pubmed-meshheading:19722747-Image Processing, Computer-Assisted,
pubmed-meshheading:19722747-Middle Aged,
pubmed-meshheading:19722747-Receptor, erbB-2,
pubmed-meshheading:19722747-Reproducibility of Results,
pubmed-meshheading:19722747-Tissue Array Analysis,
pubmed-meshheading:19722747-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis.
|
|
pubmed:affiliation |
Department of Development, HistoRx Inc, New Haven, CT 06511, USA. mgustavson@historx.com
|
|
pubmed:publicationType |
Journal Article
|
